A detailed history of Legacy Trust transactions in Merck & Co., Inc. stock. As of the latest transaction made, Legacy Trust holds 5,660 shares of MRK stock, worth $655,711. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,660
Previous 5,735 1.31%
Holding current value
$655,711
Previous $757 Million 7.4%
% of portfolio
0.17%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$123.8 - $132.96 $9,285 - $9,972
-75 Reduced 1.31%
5,660 $701 Million
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $12,021 - $13,082
-120 Reduced 2.05%
5,735 $625 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $27,261 - $29,713
-251 Reduced 4.11%
5,855 $676 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $20,588 - $22,972
200 Added 3.39%
6,106 $650 Million
Q4 2022

Apr 03, 2023

BUY
$87.44 - $112.11 $516,420 - $662,121
5,906 New
5,906 $655 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $293B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Legacy Trust Portfolio

Follow Legacy Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Trust, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Trust with notifications on news.